InsiderTrades.com logo
Mahendra Shah net worth and biography
  • Phone
  • Email
  • Website

Mahendra Shah Biography and Net Worth

Director of Verona Pharma PLC American Depositary Share

Dr Shah has served as a Non-Executive Director on our board of directors since July 2016.

Dr Shah, Senior Fellow of Vivo Capital, was formerly a Managing Partner at the healthcare investment firm. Dr Shah is also the founder and Executive Chair of Semnur Pharmaceuticals (acquired by Scilex Pharmaceuticals), a specialty pharmaceutical company. Dr Shah previously served as a board member of Soleno Therapeutics, Crinetics Pharmaceuticals, Aadi Bioscience and Homology Medicines. He currently serves as a member of the board of directors of several private companies in the biopharmaceutical and biotechnology industries. Dr Shah received his PhD in industrial pharmacy from St John’s University and a Master’s Degree in Pharmacy from LM College of Pharmacy in Gujarat, India.

What is Mahendra Shah's net worth?

The estimated net worth of Mahendra Shah is at least $9.99 million as of August 1st, 2025. Dr. Shah owns 93,472 shares of Verona Pharma PLC American Depositary Share stock worth more than $9,993,092 as of December 5th. This net worth estimate does not reflect any other investments that Dr. Shah may own. Learn More about Mahendra Shah's net worth.

How do I contact Mahendra Shah?

The corporate mailing address for Dr. Shah and other Verona Pharma PLC American Depositary Share executives is 3 MORE LONDON RIVERSIDE, LONDON X0, SE1 2RE. Verona Pharma PLC American Depositary Share can also be reached via phone at 011-44-0-2032834200 and via email at [email protected]. Learn More on Mahendra Shah's contact information.

Has Mahendra Shah been buying or selling shares of Verona Pharma PLC American Depositary Share?

Mahendra Shah has not been actively trading shares of Verona Pharma PLC American Depositary Share within the last three months. Most recently, Mahendra Shah sold 3,608 shares of the business's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $13.14, for a transaction totalling $47,409.12. Following the completion of the sale, the director now directly owns 93,472 shares of the company's stock, valued at $1,228,222.08. Learn More on Mahendra Shah's trading history.

Who are Verona Pharma PLC American Depositary Share's active insiders?

Verona Pharma PLC American Depositary Share's insider roster includes Christina Ackermann (Director), Michael Austwick (Director), James Brady (Director), Kenneth Cunningham (Director), Lisa Deschamps (Director), David Ebsworth (Director), Martin Edwards (Director), Patrick Finn (Insider), Andrew Fisher (General Counsel), Mark Hahn (CFO), Claire Poll (General Counsel), Kathleen Rickard (Insider), Mahendra Shah (Director), Vikas Sinha (Director), Anders Ullman (Director), and David Zaccardelli (CEO). Learn More on Verona Pharma PLC American Depositary Share's active insiders.

Are insiders buying or selling shares of Verona Pharma PLC American Depositary Share?

In the last year, insiders at the sold shares 30 times. They sold a total of 2,932,176 shares worth more than $29,558,114.16. The most recent insider tranaction occured on August, 1st when Director Kenneth Cunningham sold 10,808 shares worth more than $142,017.12. Insiders at Verona Pharma PLC American Depositary Share own 4.8% of the company. Learn More about insider trades at Verona Pharma PLC American Depositary Share.

Information on this page was last updated on 8/1/2025.

Mahendra Shah Insider Trading History at Verona Pharma PLC American Depositary Share

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/1/2025Sell3,608$13.14$47,409.1293,472View SEC Filing Icon  
See Full Table

Mahendra Shah Buying and Selling Activity at Verona Pharma PLC American Depositary Share

This chart shows Mahendra Shah's buying and selling at Verona Pharma PLC American Depositary Share by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verona Pharma PLC American Depositary Share Company Overview

Verona Pharma PLC American Depositary Share logo
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $106.91
Low: $106.91
High: $106.91

50 Day Range

MA: $106.65
Low: $105.91
High: $106.95

2 Week Range

Now: $106.91
Low: $31.09
High: $106.93

Volume

N/A

Average Volume

1,457,608 shs

Market Capitalization

$9.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.05